AtonRa Partners’s Twist Bioscience TWST Stock Holding History

AtonRa Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,416	Closed	-$613K	–	138
2022 Q1	$613K	Sell	12,416 -2,074	-14%	-$115K	0.33%	103
2021 Q4	$1.12M	Buy	14,490 +721	+5%	+$74K	0.39%	86
2021 Q3	$1.47M	Buy	13,769 +1,848	+16%	+$212K	0.49%	82
2021 Q2	$1.59M	Buy	11,921 +1,247	+12%	+$145K	0.58%	66
2021 Q1	$1.32M	Buy	10,674 +3,016	+39%	+$458K	0.59%	70
2020 Q4	$1.08M	Buy	+7,658	New	+$850K	0.53%	62

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

AtonRa Partners's TWST Position: Q2 2022 in Review

AtonRa Partners sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 12,416 shares — an estimated $613K sold.

AtonRa Partners first reported a position in TWST in Q4 2020 and held it in 6 quarters. The position peaked at $1.59M in Q2 2021. 203 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

AtonRa Partners reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
AtonRa Partners sold 12,416 Twist Bioscience shares in Q2 2022, an estimated $613K.
AtonRa Partners first reported a position in Twist Bioscience in Q4 2020 and held it in 6 quarters.
AtonRa Partners's Twist Bioscience position peaked at $1.59M in Q2 2021.
203 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on AtonRa Partners's 13F filing for Q2 2022, filed 15 Aug 2022.